Health Canada approves rapid COVID testing device as Canada braces for caseload spikes | CBC News
Abbott's $5 Covid-19 Rapid Antigen Test Gets Emergency-Use Status From FDA - WSJ
Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection - eClinicalMedicine
BinaxNOW: What You Need to Know | Abbott Newsroom
Abbott Test rapide Panbio™ COVID-19/Flu A&B Rapid Panel | DocCheck Shop
Health Canada approves 1st rapid antigen COVID-19 test, feds plan to buy 20 million | CBC News
Panbio™ Test rapide de l'antigène COVID-19 (nasal) d'Abbott
Orientations provisoires sur l'utilisation du test rapide de l'antigène COVID-19 d'Abbott Panbio, RMTC 47(1) - Canada.ca
Coronavirus test: FDA probes accuracy issue with Abbott's rapid COVID-19 test - 6abc Philadelphia
The White House Bet on Abbott's Rapid Tests. It Didn't Work Out. - The New York Times